Analysts optimistic about RCEL’s future growth prospects

Jaxson Clark

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AVITA Medical Inc shares valued at $45,000 were purchased by McNamara Robert on Aug 28 ’25. At $4.50 per share, McNamara Robert acquired 10,000 shares. The insider’s holdings grew to 86,771 shares worth approximately $0.34 million following the completion of this transaction.

Also, O’Toole David D purchased 2,000 shares, netting a total of over 9,040 in proceeds. Following the buying of shares at $4.52 each, the insider now holds 31,657 shares.

Before that, McNamara Robert had added 10,000 shares to its account. In a trade valued at $50,000, the Director bought AVITA Medical Inc shares for $5.00 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.3 million.

As published in a research note from BTIG Research on November 20, 2025, AVITA Medical Inc [RCEL] has been rated up from a Sell to a Neutral. Analysts at BTIG Research downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in early August. As of December 24, 2024, D. Boral Capital has initiated its “Buy” rating for RCEL. Earlier on April 11, 2024, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for RCEL stock which previously was a “a Buy”.

Analyzing RCEL Stock Performance

On last trading session, AVITA Medical Inc [NASDAQ: RCEL] rose 4.27% to $3.91. The stock’s lowest price that day was $3.75, but it reached a high of $3.925 in the same session. During the last five days, there has been a drop of approximately -1.01%. Over the course of the year, AVITA Medical Inc shares have dropped approximately -70.69%. Shares of the company reached a 52-week high of $14.16 on 01/07/25 and a 52-week low of $3.35 on 11/07/25.

Support And Resistance Levels for AVITA Medical Inc (RCEL)

According to the 24-hour chart, there is a support level at 3.80, which, if violated, would cause prices to drop to 3.68. In the upper region, resistance lies at 3.98. The next price resistance is at 4.04. RSI (Relative Strength Index) is 47.39 on the 14-day chart, showing neutral technical sentiment.

Is AVITA Medical Inc subject to short interest?

Stocks of AVITA Medical Inc saw a sharp steep in short interest on 2025-11-14 dropping by -0.15 million shares to 3.02 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 3.16 million shares. A decline of -4.87% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.12 of the overall float, the days-to-cover ratio (short ratio) decline to 12.12.

Which companies own the most shares of AVITA Medical Inc (RCEL)?

In terms of AVITA Medical Inc share price expectations, FactSet research, analysts set an average price target of 4 in the next 12 months, up nearly 6.67% from the previous closing price of $3.75. Analysts anticipate AVITA Medical Inc stock to reach 4 by 2025, with the lowest price target being 4. In spite of this, 4 analysts ranked AVITA Medical Inc stock as Buy at the end of 2025. On June 27, 2023, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and initiated coverage with a $23.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.